The British pharma company GSK has paused diversity activities for UK workers, claiming that it is obliged to do so in response to executive orders by the US president, Donald Trump.
The FTSE 100 company has also scrubbed references to “diversity” from its website. GSK is led by Emma Walmsley, one of the few women to head a FTSE 100 company.